Origin Agritech Ltd Dossier
|
SectorConsumer Staples IndustryAgricultural Products & Services Beta (adjusted)1.36 Intrinsic Value Insufficient data for a value estimateNot enough reliable inputs to publish a fair value for this company yet. Market Price $0.68Price as of 1 Oct 2026 Data confidenceNot applicable Market Cap $8.2M Enterprise Value $8.6M Shares Outstanding 12.1M diluted Next Earnings Date30 Nov 2026 All prices and values are periodic snapshots, not live quotes. Source dates are shown for reference. ThesisStreet consensus, scenarios, merits, risks, and invalidation triggers Thesis Summary Origin Agritech is undergoing a critical strategic transition, shifting away from low-margin external seed tolling services toward high-value proprietary corn seed sales and biotechnology commercialization. While the company has successfully narrowed its operating losses and achieved major scientific milestones—such as its Hi3 gene-editing technology being recognized among China's top agricultural advancements—near-term revenues remain under pressure due to the phase-out of legacy services. The long-term investment case hinges on China's regulatory timeline for GMO commercialization and Origin's ability to leverage its 200,000+ germplasm resource library to capture market share in a consolidating industry. This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today. Our research · scenarios, merits, risks, and invalidation triggersResearch as of 20 Jun 2026 Scenarios · 12-month scenario targets Bear CaseDownside scenario $0.6015% GMO commercialization in China faces further regulatory delays or policy reversals, limiting the market potential of Origin's biotech stack. Legacy revenue declines faster than proprietary sales can scale, leading to continued net losses and cash burn that may necessitate dilutive capital raises. Base CaseCentral scenario $1.2060% Origin continues its steady transition to proprietary seed sales, maintaining stable gross margins while keeping operating expenses low. Revenue for FY2026 and FY2027 stabilizes around the projected $13.43 million, and the company achieves operational cash flow breakeven by late 2026 or early 2027 as it expands its footprint in Northeast China. Bull CaseUpside scenario $2.5025% Rapid regulatory approval and commercial rollout of GMO corn in China allow Origin to aggressively monetize its proprietary insect-resistant and herbicide-tolerant traits. The 'Aoyun 2026' promotion program exceeds expectations, driving rapid adoption of new hybrid varieties like Jinqiao 8 and Jingke 317, leading to positive operating cash flow ahead of schedule. Scenarios reflect our research view at the research date. Key Investment Merits
Key Investment Risks
Thesis Invalidation Triggers
All scenarios are estimates and subject to change. Past performance is not indicative of future results. Quality Pillars MembersThis section is available to registered members. Create a free account or sign in to unlock the full breakdown. Explore this dossierValuationIntrinsic value, the six-method breakdown, peer medians, and your assumptions sandbox.Financial SnapshotRevenue, profitability, returns, balance sheet, dividends, and the filing-level detail.Qualitative AnalysisBusiness overview, strategic initiatives, and mergers, acquisitions & partnerships.Outlook & Key DatesForward estimates, reporting calendar, and the monitoring framework. |